Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at a vaccine called GV1001 for pancreatic cancer that has spread (TeloVac)

Overview

Cancer types:

Pancreatic cancer

Status:

Results

Phase:

Phase 3

Details

The TeloVac trial was to see whether giving the GV1001 vaccine as well as chemotherapy would improve treatment for pancreatic cancer. This trial was supported by Cancer Research UK.

Recruitment start: 6 March 2007

Recruitment end: 27 May 2011

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Gary Middleton

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

Kael-GemVax

National Institute for Health Research Cancer Research Network (NCRN)

Roche

Last reviewed: 23 November 2015

CRUK internal database number: 600

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

Search
An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Join
An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.

Talk